Delivery Order SPE2DB24D2012-SPE2DB25FBVHY

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,561.52 Firm Fixed Price Delivery Order is for the supply of IPOL VIAL 5ML medical products. Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.05 firm fixed-price delivery order is for IPOL VIAL 5ML medical products. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,280.82 firm fixed price delivery order is for the supply of 4565736275 ! IPOL VIAL 5ML medical products. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $190,802.88 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products, with a completion date of June 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.35 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML, with a period of performance through August 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,360.40 firm fixed-price delivery order contract is for the supply of 4566825386 ! IPOL VIAL 5ML medical products. The contract has an ultimate completion date of January 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of a wide range of medical products and supplies. The contract, valued at up to $30,953.15, is for the delivery of pharmaceutical products, including 4564615624 IPOL VIAL 5ML. This is a firm fixed price delivery order contract with a completion date of May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $16,010.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564856969 IPOL VIAL 5ML, a pharmaceutical product, with a completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.71 firm fixed-price delivery order is for medical supplies including medications, vaccines, syringes, and other medical commodities. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.28, is a Firm Fixed Price Delivery Order with a performance period through January 16, 2025. The contract provides for the delivery of medical supplies, specifically 4566945574 ! IPOL VIAL 5ML, to support federal government healthcare programs. Amerisourcebergen holds a significant...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVHY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,154.50 Firm Fixed Price delivery order contract is for the supply of 4567301266 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 19, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

The contract award did not utilize any set-aside designations, indicating open competition. Amerisourcebergen's extensive federal contracting history and role as a key vendor for various government healthcare programs, particularly within the military and veterans' healthcare systems, provide context for this award.

Generated 5/20/25, 2:25 PM